Introduction
The application of polymeric nanoparticles for the delivery of 15 therapeutic compounds exhibiting poor pharmacological profiles (e.g. low solubility and high toxicity) holds exciting promise for the treatment of many diseases, particularly cancer. [1] [2] [3] [4] [5] Nanomedicine approaches should enable improved patient compliance by reducing side-effects and administration 20 frequency. To achieve this aim it is preferable that the nanoparticles can release their cargo specifically at the site of action (normally in the cytosol). Typical release mechanisms include the GFLG peptide sequence, which is sensitive to lysosomal cathepsins, 6 or more commonly the degradation of 25 main-chains or cross-links within the constituent polymers. 7 Ester and amide linkages are routinely employed for this purpose as they slowly hydrolyse in biological milieu with the assistance of ester-/peptid-ases. For example, Harth and co-workers have reported cross-linked polyesters with potential for intracellular 30 delivery. [8] [9] These particles have been used to entrap high concentrations of hydrophobic therapeutics whilst displaying linear degradation characteristics dependent on their crystallinity. When functionalised with a targeting peptide these particles were used successfully to deliver paclitaxel to tumours exposed to 35 ionising radiation. 10 Yang et al. reported the use of polyester/DNA nanoparticles to deliver the gene for vascular endothelial growth factor into stem cells to promote limb growth in mice, 11 and Palamoor and Jablonski exploited the gradual degradation of poly(orthoesters) for ocular applications, 40 achieving delivery of epinephrine over a period of several months. 12 Perhaps the most appealing feature of polyesters is for sustained (slow) release applications. For example, cross-linked polyester nanoparticles required ~ 10 days to degrade by 82.5 % in the best 45 case, 8 whilst emulsion-derived polyesters degraded by only ~ 50 % after several months. 13 However, the non-specific degradation mechanism of such functionality poses two challenges: unwanted, non-specific cargo leaching of targeted delivery agents, and the generation of acidic side-products due to ester hydrolysis. 14-15 For 50 instance, the generation of acid within degrading microparticles of poly(lactic-co-glycolic acid) led to regions with pH as low as 1.5 after several days. 16 An alternative degradable linkage is the disulfide bond which is sensitive to the primary in vivo reducing agent glutathione (GSH). GSH is attractive given the 1000-fold 55 concentration differential between intra-and extracellular environments. 17 This gradient has been exploited to ensure nanocarriers are stable in the circulation, but rapidly disassemble in the intracellular environment. [18] [19] [20] [21] Zhong and co-workers compared the rate of doxorubicin release from 60 poly(ethyleneglycol)-block-poly(caprolactone) micelles with and without a disulfide linker in a reducing environment. Complete drug release from the disulfide-containing micelles occurred after 10 hours whilst only 20 % doxorubicin was released via ester hydrolysis from the non-disulfide containing structures, 65 highlighting the advantage of bioreduction over ester hydrolysis when rapid release is desirable. [22] [23] However, introduction of disulfide linkages between two distinct polymer blocks can require macromolecular coupling reactions which are not always efficient and require extensive purification. 22 We have previously 70 incorporated a disulfide linkage into thermoresponsive polymers whereby the lower critical solution temperature (LCST) can be modulated in response to intracellular GSH. This enabled the soluble-insoluble transition associated with an LCST to be manipulated using biochemical-triggers rather than temperature 75 changes, an "isothermal" transition. [24] [25] [26] [27] Other examples of isothermal responses include the use of salt gradients, 28 redoxactive spin labels 29 and bacterial binding, 30 the key advantage of which is that known responsive polymers can be easily modified to initiate complex responses under more biologically relevant 80 conditions. The incorporation of redox and thermally responsive components into nanoparticles via complex block copolymer self-assembly is particularly challenging from a synthetic perspective. Alternatively, nanoprecipitation (or interfacial deposition) has emerged as a facile alternative for the preparation of 5 nanoparticles requiring only a hydrophobic polymer. Benefits of this methodology include fast processing times, control over particle size and the ready inclusion of cargo molecules. [31] [32] However, the need for hydrophobic polymers has essentially constrained this technique to poly(esters), plus some examples of 10 poly(styrenes). 32 In this manuscript we prepare nanoparticles from thermoresponsive polymers containing a disulfide-linked 'solubility release catch' at their chain-end by the nanoprecipitation technique. This release catch is designed to 15 promote rapid nanoparticle disassembly and cargo release upon encountering intracellular levels of GSH. Furthermore, reduction of the end-group switches the material's LCST rendering the polymer and resulting by-products fully hydrophilic.
Results and Discussion
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We reasoned that thermoresponsive polymers displaying an LCST could be used to prepare particles via nanoprecipitation if they were held above their transition temperature. Furthermore, by introducing a redox-responsive chain-end 'solubility release catch' to generate an isothermal response, it should be possible to 25 programme the polymer such that its LCST increases in the presence of intracellular GSH. This will allow the particle solubility to switch, triggering disassembly and cargo release using only end-group reduction events rather than random degradation of the polymer backbone. Furthermore, the released 30 polymer will be hydrophilic and of sufficiently low molecular weight to be removed by renal elimination, without the need for polymer degradation (Figure 1 ). In this study poly(N-isopropylacrylamide), PNIPAM, was selected as the responsive polymer given its strong shift in cloud point (measurable property of the LCST) upon polymer endgroup modification provides the desired 'solubility release 40 catch'. [24] [25] 30 PNIPAMs were prepared using a pyridyl disulfide (PDS)-functionalised RAFT agent and were characterised by 1 H NMR, SEC and turbidimetry (Supp. Info.). PNIPAM-1 with M n = 25400 g.mol -1 , M w /M n = 1.24 and cloud point ~ 32 °C was selected for use here, Scheme 1. Figure  2A ) and demonstrated colloidal stability for 7 days without 55 aggregation. As the particles prepared with this particular polymer must be held above the polymer cloud point (to be hydrophobic), cryogenic transmission electron microscopy (cryo-TEM) with rapid vitrification was employed. Cryo-TEM of these soft, responsive, nanoparticles is non-trivial, but with the rapid 60 cooling it was possible to visualize the nanostructures. As exemplified by Figure 2A , cryo-TEM revealed nanoparticles with mean diameter of 138 nm, which is in broad agreement with the DLS data. These differences can be rationalised by considering the average particle size provided by cryo-TEM is a number 65 average compared to the z-average provided by DLS. Additional images and image-analysis are included in the Supporting Information.
To ensure that the resulting particles retained the intrinsic thermo-responsiveness of their constituent polymer, temperature-70 dependent DLS was conducted ( Figure 2B ). As the nanoparticles were cooled from 50 to 20 °C a decrease in scattering intensity (count rate) was observed indicating disassembly of the particles. This was also confirmed by the visual change from an opalescent suspension to a colourless solution. An overlay of this DLS data 75 with turbidimetric analysis of PNIPAM-1 indicated that disassembly correlated with the cloud point of the polymer. The principal aim of this study was to evaluate whether the nanoparticles would specifically disassemble in response to intracellular levels of GSH via reduction of the PDS solubility release catch. To verify a GSH-induced physical response, the 10 nanoparticles were held at 50 °C, GSH was added at 10 μM (extracellular) or 1 mM (intracellular) and the particle size measured. Addition of 10 µM GSH showed no changes visually, or by DLS. In contrast, addition of 1 mM GSH resulted in rapid precipitation of the nanoparticles ( Figure 3A , inset) and a 15 significant increase in the particle size to ca. 1.5 microns. It should be noted that this experiment is not intended to mimic in vivo conditions, but to demonstrate the concept of isothermal disassembly. Hence, aggregation is observed as the experimental temperature, which is above the cloud point of both the original 20 and GSH-modified polymer (see Supp. Info.), means the resulting disassembled polymer chains exist in a globular conformation. Further exemplification under more physiological conditions, leading to dissolution of the polymers is described later (vide infra). A fluorescent probe, diphenylhexatriene (DPH), was encapsulated in the particle by co-precipitation as a model cargo. DPH only fluoresces in hydrophobic environments allowing direct observation of its release into an aqueous environment. Addition of up to 10 µM GSH caused no decrease in fluorescence intensity, with the slight increase observed attributable to evaporation given the elevated (50 °C) temperatures being used. Addition of 1 mM GSH led to an almost immediate decrease in fluorescence intensity demonstrating that particles assembled 40 from thermoresponsive polymers are capable of releasing a cargo in response to a biochemical stimulus ( Figure 3B ). The observed release agreed with DLS data and confirmed the polymer phase transition as the trigger. Release was both specific, yet significantly faster than that observed with disulfide-linked 45 micelles which required over 10 hours 7 or 40 hours 34 to release their cargo. We believe the fast release kinetics may be due to the cooperative nature of pNIPAM's LCST; if a small fraction of the polymer chains undergo an increase in their LCST (due to bioreduction), then the LCST of those remaining is also raised, 50 facilitating disassembly. 35 This cooperative LCST behaviour is not found with all thermoresponsive polymers, such as poly[oligo (ethyleneglycol)methacrylates], highlighting the importance of the choice of PNIPAM. 35 Other polymers with co-operative LCST behaviour include elastin-side chain poly(methacrylates) 36 and poly(N-vinyl lactams). The observation may also be explained by considering the location of encapsulated material in different nanoparticle structures. For example, cross-linked 5 micelles contain hydrophobic cargo within the core. In our particles however, we expect the cargo molecules to be diffusely spread throughout the structure, meaning cargo release occurs as soon as the outer polymers pass through their phase transition.
To ensure that any LCST change was due to reduction of the 10 pyridyl disulfide α-end-group by the cysteine residue present in GSH, and not displacement of the trithiocarbonate ω-end-group by the glutamic acid residue (Supp. Info. for mechanism), control UV-Vis experiments were performed using two trithiocarbonatecontaining PNIPAM samples of similar molecular weights. The 15 samples differed by their α-end-group: PNIPAM-2 and PNIPAM-3 contained a tert-butyl carbamate and PDS group respectively (see Supp. Info for characterisation). The distinctive UV-Vis absorption of the RAFT agent at 309 nm was monitored as a function of GSH concentration and no change in absorbance was 20 observed with PNIPAM-2 (see Supp. Info.). A slight increase in absorbance at 309 nm and 343 nm was observed with PNIPAM-3 and was attributed to the release of pyridine thione, a by-product of thiol-PDS exchange, whose spectrum exhibits some absorbance overlap with that of the trithiocarbonate (Figure 4 ). The motivation for using an isothermally responsive polymer nanoparticle, as opposed to a conventional hydrophobic polymer, lies in the solubility switch observed upon end-group bioreduction. PNIPAM-1 had an LCST ~ 32 °C which is not suitable for an in vivo application, therefore statistical 35 copolymers of NIPAM and N-hydroxyethyl acrylamide (HEA) were prepared and their thermoresponsivity measured (Supp. Info.). The polymer with 5 mol % HEA was found to have a cloud point ~ 35 °C at 0.5 mg.mL -1 which increased to ~ 37 °C upon GSH reduction ( Figure 5A ). This polymer was used to form 40 nanoparticles with diameter ~ 200 nm (DLS and cryoTEM in Supp. Info.). The nanoparticles were stable at 37 °C and in the presence of 10 µM GSH, the extracellular concentration. Increasing the GSH concentration to 1 mM (as found in many intracellular compartments) resulted in particle disassembly (blue 45 suspension to colourless solution) and dye release experiments showed quenching of DPH fluorescence ( Figure 5B ). This demonstrates that by fine-tuning the polymer structure and hence transition temperature, isothermal disassembly can be employed to trigger cargo release from nanoparticles specifically in 50 response to biochemical triggers. We anticipate that this concept could also be translated to degradable thermoresponsive polymers such as elastin-based peptides 37 or poly(phosphoesters). 
Conclusions
To summarise, this manuscript demonstrates the use of 60 isothermally responsive polymers which are capable of shifting their phase behaviour upon the application of the specific biochemical stimulus glutathione. Nanoparticles were formed by holding PNIPAM above its transition temperature allowing the use of nanoprecipitation; a method typically associated with 65 hydrophobic polymers. The nanoparticles were shown to specifically disassemble and release a cargo upon exposure to intracellular levels of glutathione with complete release in around 30 minutes. The fast, but highly specific release kinetics offers a significant advantage over other reducible carriers such as 70 micelles. Importantly the particles were stable for extended periods in the presence of circulatory-levels of glutathione which is essential for a disulfide-linked delivery system where cargo leaching is undesirable. The mechanism of disassembly was shown to be due to the isothermal phase transition of the 75 PNIPAM, caused by rapid and selective cleavage of the disulfidelinked end-group. The ability to tune this transition temperature using simple co-polymerisation methodologies was also demonstrated to generate responses at physiological temperatures. This report represents a powerful strategy to 80 generate nanoparticles from hydrophilic polymers, without the need for cross-linking or block copolymers. Furthermore, these structures can be tuned to trigger release in response to specific cellular stimuli without requiring a non-specific polymer degradation step. Future work will include in vitro assessment of 85 drug delivery, the incorporation of degradable functionality into the polymer main-chain and targeting functionalities.
Experimental Section
Synthetic Procedures
The synthesis and characterisation of the functionalised RAFT agents and polymers are described in the Supporting Information.
General Procedure for Nanoparticle Preparation
Polymer (5 mg) was dissolved in acetone (5 mL) and added dropwise to a round bottom flask containing a stir bar and deionised water (10 mL) held at 50 °C over a period of one hour. were: end plate offset at -500 V; capillary at -4500 V; nebulizer gas (N 2 ) at 1.6 bar; dry gas (N 2 ) at 8 L.min -1 ; dry temperature at 180 °C. Ion tranfer conditions were: ion funnel RF at 400 Vpp; multiple RF at 400 Vpp; quadruple low mass set at 455 m/z; collision energy at 5.0 eV; collision RF at 1200 Vpp; ion cooler 35 RF at 250-600 Vpp; transfer time set at 121 µs; pre-pulse storage time set at 15 µs. Calibration was completed with sodium formate (10mM). FTIR spectra were acquired using a Bruker Vector 22 FTIR spectrometer with a Golden Gate diamond attenuated total reflection cell. A total of 64 scans were collected on samples in 40 their native (dry) state. UV-visible spectra were obtained using an Agilent Cary 60 UV-visible spectrophotometer at a "medium" scan-speed. SEC analysis was performed on a Varian 390-LC MDS system equipped with a PL-AS RT/MT autosampler, a PLgel 3 µm (50 × 7.5 mm) guard column, two PL-gel 5 µm (300 × Fluorescence measurements were performed using a Biotech Synergy HT and processed using the Gen5 software package. Particle size analysis was determined by Dynamic Light 60 Scattering using a Malvern Zetasizer Nano ZS instrument. A 4 mW He-Ne 633 nm laser module was used and scattered light was measured at 173° (back scattering). The attenuator and position was selected automatically by the instrument.
Cryogenic Transmission Electron Microscopy samples (0.5 65 mg/mL in water) were examined using a Jeol 2010F TEM operated at 200 kV and imaged using a GatanUltrascan 4000 camera. Images were captured using Digital Micrograph software (Gatan). A 3 µL droplet of the sample solution held at 50 °C was rapidly transferred to a holey carbon-coated copper grid, and the 70 grid was blotted to remove excess solution. Subsequently, the grid was plunged into liquid ethane to vitrify the sample. The temperature of the cryogenic stage was maintained below -170 °C, using liquid nitrogen, during imaging. Where appropriate, particle size analysis was performed using ImageJ.
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Nanoparticle Fluorescence Assay A generalised procedure for the fluorescence assay is as follows. Nanoparticles (190 µL) were incubated in a 96-well plate at 50 °C for 1 hour. 10 µL water or concentrated glutathione solution 80 was added to give final glutathione concentrations of 0, 0.01 and 1 mM and the fluorescence monitored over a period of 2 hours. Excitation wavelength set at 360 nm, emission wavelength at 460 nm and the plate maintained at 50 °C throughout. 85 
